Comparison between analytic and anamnestic data about drug consumption among opiate addicts with substitutes therapy. A feasibility study;Comparaison des données analytiques et anamnestiques des consommations de drogues et psychotropes chez des usagers dopiacés entraitement de substitution. Étude de faisabilité

Therapie

Volumn 64, Issue 4, 2009, Pages 269-277

  Bourgine, Joanna ^a   Ma, Lin Lin ^a   Boisselier, Reynald Le ^a   Paillet Loilier, Magalie ^a   Albessard, Françoise ^a   Lelong Boulouard, Véronique ^a   Vigneau, Caroline ^b   Jolliet, Pascale ^b   Debruyne, Danièle ^a   Coquerel, Antoine ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b Service de Pharmacologie   (France)

Author keywords

Drug therapy; Epidemiology; Opiate addiction; Toxicology; Urine

Indexed keywords

ALPRAZOLAM; BROMAZEPAM; BUPRENORPHINE; CANNABIS; CLONAZEPAM; COCAINE; DIAZEPAM; DRUG METABOLITE; FLUNITRAZEPAM; FLUOXETINE; ILLICIT DRUG; METHADONE; MORPHINE 6 ACETATE; NORBUPRENORPHINE; NORCODEINE; NORDAZEPAM; OPIATE; OXAZEPAM; PRAZEPAM; PSYCHOTROPIC AGENT; RECREATIONAL DRUG; TEMAZEPAM; TETRAZEPAM; ZOLPIDEM; ZOPICLONE;

ADULT; ANALYTIC METHOD; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DATA ANALYSIS; DIODE; DRUG DEPENDENCE; DRUG USE; FEASIBILITY STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOLOGICAL PROCEDURES; INFORMATION PROCESSING; LEGAL ASPECT; LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; OBSERVATIONAL METHOD; OPIATE ADDICTION; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; REHABILITATION CENTER; SELF REPORT; SUBSTITUTION THERAPY; TOXICOLOGICAL PARAMETERS; URINALYSIS;

EID: 70449574720     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie/2009043     Document Type: Article

References (26)

1. Observatoire français des drogues et des toxicomanies. Drogues, chiffres clés. http://www.academie-medecine.fr/UserFiles/File/rapports- thematiques/drogues/ofdt2008(1).pdf
2. Association Nationale des Intervenants en Toxicomanie et addictologie. Traitements de substitution à la buprénorphine : l'expérience française (A. Morel, 2000). http://www.anitea.fr/ documents/subutex-intro. php
3. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Int Med 2001; 134: 968-977
4. Moriski DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74
5. Sackett DL, Heynes RB, Gibson ES. Randomized clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1975; 1: 1205-1210
6. Ghitza UE, Epstein DH, Preston KL. Nonreporting of cannabis use: predictors and relationship to treatment outcome in methadone maintained patients. Addict Behav 2006; 32: 938-949
7. Manchikanti L, Manchukonda R, Pampati V, et al. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Pain Physician 2006; 9: 123-129
8. Jaffee WB, Trucco E, Levy S, et al. Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing. J Subst Abuse Treat 2007; 33: 33-42
9. Braithwaite RA, Jarvie DR, Minty PS, et al. Screening for drugs of abuse. (I): Opiates, amphetamines and cocaine. Ann Clin Biochem 1995; 32: 123-153
10. Simpson D, Braithwaite RA, Jarvie DR, et al. Screening for drugs of abuse. (II): Cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs. Ann Clin Biochem 1997; 34: 460-510
11. Maurer HH. Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control. Clin Chem Lab Med 2004; 42: 1310-1324
12. Roussac F, Roussac A. Analyses chimiques. Méthodes et techniques instrumentales modernes. 6e édition. Dunod Ed., Paris, 462 p, 2004
13. Pirnay S, Hervé F, Bouchonnet S, et al. Liquid chromatographic-electrospray ionization mass spectrometric quantitative analysis of buprenorphine, norbuprenorphine, nordiazepam and oxazepam in rat plasma. J Pharm and Biomed Analysis 2006; 41: 1135-1145
14. Pirnay SO, Abraham TT, Huestis MA. Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine. Clin Chem 2006; 52: 1728-1734
15. Romberg RW, Lee L. Comparison of the hydrolysis rates of morphine-3- glucuronide and morphine-6-glucuronide with acid and â-glucuronidase. J Anal Toxicol 1995; 19: 157-162
16. Wang P, Stone JA, Chen KH, et al. Incomplete recovery of prescription opioids in urine using enzymatic hydrolysis of glucuronide metabolites. J Anal Toxicol 2006; 30: 570-575
17. Borrey D, Mayer E, Duchateau L, et al. Enzymatic hydrolysis improves the sensitivity of emit screening for urinary benzodiazepines. Clin Chem 2002; 48: 2047-2049
18. Klette KL, Wiegand RF, Horn CK, et al. Urine benzodiazepine screening using Roche Online KIMS immunoassay with beta-glucuronidase hydrolysis and confirmation by gas chromatography-mass spectrometry. J Anal Toxicol 2005; 29: 193-200
19. Vignau J, Duhamel A, Catteau J, et al. Practice-based buprenorphine maintenance treatment (BMT): how do french healthcare providers manage the opiate-addicted patients? J Substance Abuse treatment 2001; 21: 135-144
20. Gandilhon M. Le petit trafic de Cocaïne en France. Tendancesn 53. Avril 2007. OFDT http://www.ofdt.fr/ofdtdev/live/publi
21. Office central pour la répression du trafic illicite des stupéfiants (OCRTIS). Usage et trafic des produits stupéfiants en France en 2005. OCRTIS, Nanterre, 2006
22. Observatoire français des drogues et des toxicomanies. Cocaïne et crack : consommation. http://www.ofdt.fr/ofdtdev/live/produits/ cocaine/conso.html#aff-rech
23. Observatoire français des drogues et des toxicomanies. Le trafic du cannabis en France 2007. http://www.ofdt.fr/ofdtdev/live/publi/rapports/ rap07/epfxcbnc.html
24. Staub C, Marset M, Mino A, et al. Detection of acetylcodeine in urine as an indicator of illicit heroin use: method validation and results of a pilot study. Clin Chem 2001; 47: 301-307 (Pubitemid 32142929)
25. Pépin G. Opiacés et opioïdes. In: Kintz P (coordinateur). Toxicologie et Pharmacologie médicolégales. Paris: Elsevier, Collection Option Bio, 1998: 335-430
26. Ragoucy-Sengler C. Cocaïne. In: Kintz P (coordinateur). Toxicologie et Pharmacologie médicolégales. Paris: Elsevier, Collection Option Bio, 1998: 431-463